FeLV: whole-blood detection and survival by diagnostic classification
Journal of feline medicine and surgery · 2025
In plain language
The study followed 127 cats: those classified as high positive had a lower probability of survival than low positive or cryptic/negative cats. In low positive cats, the SNAP test detected a FeLV protein more often in whole blood than in plasma or serum when they entered the study. The study could not determine what caused the deaths or whether low positive cats that died had become high positive. Only blood samples were examined, so possible infection confined to bone marrow or lymphatic tissue was not investigated.
Scientific detail
This observational clinical study, published in Journal of feline medicine and surgery in 2025, included 127 cats: 90 high positive, 29 low positive and eight cryptic/negative. Baseline diagnostic classification was associated with subsequent survival: high positive cats had a lower survival probability than low positive or cryptic/negative cats. This association does not demonstrate causality. The evidence is conservatively classified as level C because it comes from an unreplicated observational cohort with no reported separate uninfected control group.
Among the 29 low positive cats, SNAP detected FeLV p27 antigen more frequently in whole blood than in plasma or serum at enrollment. This within-cohort comparison of sample types does not establish diagnostic specificity in uninfected cats or identify malignant disease. Sampling was restricted to peripheral blood; examination of bone marrow or lymphoid tissue might have revealed focal virus or the source of circulating antigen or provirus. Focal infection in these tissues was not demonstrated, and an oncogenic reservoir was not established. Salivary viral RNA was not assessed either.
Additional FeLV testing and necropsies at death were unavailable, preventing determination of end-of-life viral load, cause of death or whether low positive cats that died had transitioned to high positive status. Baseline classification therefore does not describe infection status at death. Because infection duration before shelter admission was unknown, survival was measured from enrollment rather than initial infection. Six cats were lost to follow-up.
From an oncology perspective, the study provides prognostic context but does not establish lymphoma or leukemia incidence, mechanisms of malignant transformation or cancer-specific causes of mortality. The survival differences cannot be attributed to lymphoma, leukemia or another specific cause of death on the basis of these data. Peripheral-blood testing alone also did not characterize potential bone marrow or lymphoid tissue reservoirs.
What we know
In this cohort of 127 cats, high positive status at baseline was associated with a lower survival probability than low positive or cryptic/negative classification, without demonstrating causality. In the 29 low positive cats, SNAP detected FeLV p27 antigen more frequently in whole blood than in plasma or serum at enrollment. The evidence is level C: it comes from an unreplicated observational cohort with no reported separate uninfected control group.
What we don't know
End-of-life viral load, causes of death and whether low positive cats that died had transitioned to high positive status remain unknown. Potential focal infections or reservoirs in bone marrow or lymphoid tissue were not characterized, and salivary viral RNA was not assessed. Infection duration before shelter admission was unknown, and six cats were lost to follow-up. The study does not establish diagnostic specificity in uninfected cats, lymphoma or leukemia incidence, mechanisms of malignant transformation or cancer-specific mortality.
Evidence
EvidenceLevel C — Preliminary evidenceConfidence 100/100
In low positive cats, SNAP detected FeLV p27 antigen more frequently in whole blood than in plasma or serum at enrollment.
Excerpt verified in the source — verbatim, in the source's own language“Whole blood detected 28/29 (97%, 95% CI 83–99), plasma detected 23/29 (79%, 95% CI 62–90) and serum detected 19/29 (66%, 95% CI 47–80), suggesting that whole blood was significantly more sensitive than serum.”
This is a within-cohort comparison of sample types in 29 low positive cats. It does not establish diagnostic specificity in uninfected cats or identify malignant disease. Evidence is conservatively classified as C for this unreplicated observational cohort without a separate uninfected control group.
EvidenceLevel C — Preliminary evidenceConfidence 99/100
Restricted peripheral-blood sampling left potential focal infection in bone marrow or lymphoid tissue uncharacterized.
Excerpt verified in the source — verbatim, in the source's own language“A limitation of this study was that sampling was restricted to the minimally invasive collection of peripheral blood for FeLV testing. More invasive sampling of tissues such as bone marrow or lymphoid tissue may have revealed virus harbored in focal infections or the source of antigen or provirus found in circulation.”
The authors identify a sampling limitation and a possible benefit of tissue examination. They do not demonstrate focal tissue infection in these cats or establish an oncogenic reservoir.
EvidenceLevel C — Preliminary evidenceConfidence 100/100
High positive cats had lower survival probability than low positive or cryptic/negative cats.
Excerpt verified in the source — verbatim, in the source's own language“Survival probability was significantly lower for high positive cats than for low positive or cryptic/negative cats ( P <0.0001)”
The Figure 5 caption reports an association between baseline diagnostic classification and survival. This is not evidence that lymphoma or leukemia caused the survival difference, and it does not demonstrate causality.
EvidenceLevel C — Preliminary evidenceConfidence 100/100
The study could not determine end-of-life viral load or cause of death because additional FeLV testing and necropsies were unavailable.
Excerpt verified in the source — verbatim, in the source's own language“Another limitation was the inability to perform additional FeLV testing or necropsies at the time of death to determine viral load at the end of life or the cause of death.”
Reported survival differences cannot be assigned to lymphoma, leukemia or another specific cause of death on the basis of this study.
Open questionConfidence 100/100
Whether low positive cats that died had transitioned to high positive status remains unresolved.
The authors explicitly state that this transition could not be established. Baseline classification therefore does not describe infection status at death.
Provenance
Source: Feline leukemia virus lifetime study: whole blood samples increase detection of low positive cats with extended long-term survival.
AVA